TrialEuropean journal of neurology2023

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial.

Ettore Beghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.